PRODUCT DETAILS

About Healace Gel

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR belongs to the group of growth factors used in the treatment of diabetic foot ulcers, bedsores, chronic leg ulcers, and vascular ulcers. A diabetic foot ulcer is an open wound in diabetic patients that occurs due to uncontrolled diabetes. It appears as a red crater on the skin. It mostly affects the bottom or top of the foot and tip of a toe.

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR contains recombinant human epidermal growth factor which is a protein that stimulates cell growth. It acts by releasing a growth factor that can promote tissue repair, skin regeneration (formation of healthy skin), and accelerate wound healing. These effects help to reduce skin ulcers in diabetic foot ulcer patients.

Uses of Healace Gel

Diabetic foot ulcer, bedsore, chronic leg ulcers and vascular ulcers

Medicinal Benefits of Healace Gel

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR contains recombinant human epidermal growth factor, an endogenous growth factor that helps in wound healing and new cell production. It is a glycoprotein that binds to epidermal growth factor receptors, enhancing the processes responsible for cellular proliferation, new cell production, collagen synthesis, and reduced cell death, thereby amplifying wound healing and finding major application in the treatment of diabetic foot ulcers, bedsore, chronic leg ulcers and vascular ulcers.

Directions for Use

Always use RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR in the dose prescribed by your doctor. It is meant for external applications. Apply a thin layer with a cotton swab. Thoroughly wash your hands after application. Let the area air-dry before dressing.

Side Effects of Healace Gel

• Headache
• Abdominal pain
• Nausea
• Rash
• Pruritis

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

It is advisable to inform the doctor if you are allergic to any of the components in RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR. Keep your doctor informed if you suffer from hypersensitivity. Avoid RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR in case of an immunocompromised state such as HIV. Inform your doctor if you are on treatment with any corticosteroids, or are on any vaccines, immunosuppressants or immunostimulators. Avoid using RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR if you are pregnant or breastfeeding.

Drug Interactions

Drug-Drug Interaction:

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR may interact with immunosuppressants (mycophenolate mofetil, azathioprine, mercaptopurine), immunostimulants (thalidomide, levamisole) and anti-convulsant (carbamazepine).

Drug-Disease Interaction:

 RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR should be used with caution in patients with a known hypersensitivity disorder and HIV.

Safety Advice

ALCOHOL

There is not enough literature on the effects of alcohol on RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR. Exercise caution before taking alcohol with RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR. Please consult your doctor if you have any concerns.

PREGNANCY

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR is not recommended for use by pregnant women. Please consult your doctor if you have any concerns.

BREAST FEEDING

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR is not recommended during nursing. Please consult your doctor if you have any concerns.

DRIVING

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR is unlikely to affect your ability to drive.

LIVER

Please consult your doctor in case of any concerns.

KIDNEY

Please consult your doctor in case of any concerns.